ProText Mobility, Inc. (TXTM)
OTCMKTS · Delayed Price · Currency is USD
0.0068
+0.0003 (4.62%)
Apr 23, 2026, 11:20 AM EST
ProText Mobility Market Cap
ProText Mobility has a market cap or net worth of $57.14 million as of April 23, 2026. Its market cap has increased by 622.22% in one year.
Market Cap
57.14M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 3, 2017, ProText Mobility's market cap has increased from 584.01K to 57.14M, an increase of 9,684.63%. That is a compound annual growth rate of 63.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 55.30M | 85.00% |
| Dec 31, 2025 | 29.89M | 240.00% |
| Dec 31, 2024 | 8.79M | -41.18% |
| Dec 29, 2023 | 14.95M | 19.00% |
| Dec 30, 2022 | 12.56M | 21.42% |
| Dec 31, 2021 | 10.34M | 276.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 178.13M |
| HST Global | 88.40M |
| BioStem Technologies | 80.21M |
| Nuo Therapeutics | 66.31M |
| Cell Source | 57.07M |
| Vicapsys Life Sciences | 47.26M |
| Harvard Apparatus Regenerative Technology | 29.54M |
| Provectus Biopharmaceuticals | 22.57M |